Leland Gershell

Stock Analyst at Oppenheimer

(0.96)
# 1992
Out of 5,329 analysts
149
Total ratings
40.71%
Success rate
-2.80%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
QNCX Quince Therapeutics
Initiates Coverage On: Outperform
10
1.08 825.93% 1 Mar 24, 2025
TRVI Trevi Therapeutics
Maintains: Outperform
12 20
7.17 178.94% 3 Mar 11, 2025
ARGX argenx
Maintains: Outperform
675 704
654.28 7.6% 6 Feb 28, 2025
BMRN Biomarin Pharmaceuti...
Upgrades: Outperform
98
63.58 54.14% 3 Feb 24, 2025
RYTM Rhythm Pharmaceutica...
Initiates Coverage On: Outperform
76
64.63 17.59% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
190 180
178.39 0.9% 10 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 52
21.93 137.12% 2 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
135 147
110.85 32.61% 2 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.53 843.4% 8 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 73
75.87 -3.78% 8 Oct 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
40 40
11.61 244.53% 9 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 53
16.25 226.15% 3 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 1 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 43
12.87 234.11% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
3.72 706.45% 2 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
1.65 627.27% 2 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
150 25
0.52 4707.69% 9 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
31 28
13.77 103.34% 5 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 25
3.52 610.23% 3 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 73
34.34 112.58% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
n/a n/a 5 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 20
1.53 1207.19% 5 Jul 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
29 29
24.83 16.79% 3 Jun 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
35
5.04 594.44% 2 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 10
0.76 1215.79% 1 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
5
4.51 10.86% 1 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 20
1.33 1403.76% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 7 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
1.35 862.96% 3 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
150 120
3.8 3057.89% 1 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 1 Oct 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Aug 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
140
n/a n/a 1 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
36
n/a n/a 4 Dec 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Dec 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 1 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
360000
n/a n/a 1 Jun 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Nov 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
1.99 2412.56% 1 Oct 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4620 1470
n/a n/a 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
225
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
112 115
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
16 17
n/a n/a 2 May 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Perform
n/a
n/a n/a 4 Mar 31, 2020